BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30927972)

  • 1. Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Chua CC; Fleming S; Wei AH
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):3-12. PubMed ID: 30927972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?
    Madanat YF; Gerds AT
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):104-113. PubMed ID: 30927969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis and therapy related MDS/AML.
    Desai P; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Klimek VM
    Curr Opin Hematol; 2013 Mar; 20(2):137-43. PubMed ID: 23343830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
    Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
    Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.
    Woodard P; Barfield R; Hale G; Horwitz E; Leung W; Ribeiro R; Rubnitz J; Srivistava DK; Tong X; Yusuf U; Raimondi S; Pui CH; Handgretinger R; Cunningham JM
    Pediatr Blood Cancer; 2006 Dec; 47(7):931-5. PubMed ID: 16155933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 signaling and inhibition in AML and MDS.
    Haroun F; Solola SA; Nassereddine S; Tabbara I
    Ann Hematol; 2017 Sep; 96(9):1441-1448. PubMed ID: 28643044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.
    Yamasaki S; Suzuki R; Hatano K; Fukushima K; Iida H; Morishima S; Suehiro Y; Fukuda T; Uchida N; Uchiyama H; Ikeda H; Yokota A; Tsukasaki K; Yamaguchi H; Kuroda J; Nakamae H; Adachi Y; Matsuoka KI; Nakamura Y; Atsuta Y; Suzumiya J
    Bone Marrow Transplant; 2017 Jul; 52(7):969-976. PubMed ID: 28368379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.
    Sengsayadeth S; Gatwood KS; Boumendil A; Labopin M; Finke J; Ganser A; Stelljes M; Ehninger G; Beelen D; Niederwieser D; Blaise D; Dreger P; Mufti G; Chevallier P; Mailhol A; Gilleece MH; Gorin N; Esteve J; Ciceri F; Baron F; Schmid C; Giebel S; Mohty M; Savani BN; Nagler A
    Blood Adv; 2018 Aug; 2(16):2127-2135. PubMed ID: 30143527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapy.
    de Witte T; Oosterveld M; Span B; Muus P; Schattenberg A
    Rev Clin Exp Hematol; 2002 Mar; 6(1):72-85; discussion 86-7. PubMed ID: 12060485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related myelodysplastic syndromes in the genomics era.
    Renneville A; Bernard E; Micol JB
    Bull Cancer; 2023 Nov; 110(11):1129-1140. PubMed ID: 37391357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances of studies on the therapy-related myelodysplastic syndromes/acute myeloid leukemia].
    Li CJ; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1757-60. PubMed ID: 25543511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
    Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
    Ballen KK; Antin JH
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
    Chung A; Liedtke M
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
    Stem Cells Dev; 2014 Jul; 23(14):1559-67. PubMed ID: 24617310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.
    Rautenberg C; Germing U; Stepanow S; Lauseker M; Köhrer K; Jäger PS; Geyh S; Fan M; Haas R; Kobbe G; Schroeder T
    Am J Hematol; 2021 Jan; 96(1):E15-E17. PubMed ID: 33017477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.